stem-cell-research

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replac…

The BMJ retracts stem cell trial amid ongoing data integrity and reliability concerns The BMJ has retracted a clinical trial published on 29 October 2025: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8). The decision follows an investigation by BMJ Group's content integrity team …

The first UK Stem Cell Network Conference was an inspiring showcase of collaboration and innovation in regenerative medicine. Wondering what to expect from a UKSCN event or whether it’s worth attending next time? Here’s Aarushi's experience from the inaugural meeting in Manchester. Introduction The UK Stem Cell Network (UKSCN) encourages inclusive collaboration and innovation for stem cell-based …

Guanyi Huang — now associate principal scientist at MerckBodye — credits his USC training with putting him at the forefront of biological research breakthroughs. The post Trojan’s long fascination with molecular biology inspires stem cell career appeared first on USC .

Jay Bhattacharya just got confirmed to lead the NIH yesterday. In that role, there are reasons to think he may discourage or even stop some important research and funding. As a stem cell biologist, I’ve been looking out for indications of possible restrictions on our field’s work during the new administration. Bhattacharya’s statements signal potential […] The post NIH Director Jay Bhattacharya c…

An unproven Georgia stem cell clinic called Superior Healthcare and other co-defendants recently lost a key court case. Some of you may remember that the Attorney General (AG) of Georgia Chris Carr and the FTC have been collaborating on this case. Now we have the good news that they have won the case via a […] The post Georgia AG & FTC win Superior Healthcare stem cell clinic case, seek $17 milli…

“Stem cells possess the potential to transform into particular cell types, offering promising avenues for rejuvenating and restoring tissues harmed by injury or affected by disease,” said principal investigator Craig Walsh, UCI professor of molecular biology and biochemistry.

It’s another one of those ‘double-grant’ weekends of grant writing (on brain cancer) and reviewing, but I’m still trying to find a bit of time for some other reading. There was some important news this week including a big mess of problematic papers at Dana Farber Cancer Institute (DFCI). Recommended reads Here’s the new WaPo […] The post Weekly stem cell reads: cancer paper mess at DFCI, H3.3, k…

In today’s post, I reviewed a stem cell clinic firm called Docere Clinics. In my opinion, there are some concerning issues here and reasons for caution. One type of procedure at Docere is particularly surprising and raises risks in my view. What is Docere Clinics? | What kind of stem cells does Docere use? | What they […] The post Review of Docere Clinics run by Harry Adelson including total-body…

When people find out that I’m a stem cell researcher, a common question is whether there’s something they can take that is a stem cell activator. I’ve written before about whether there are stem cell boosts that one can do to try to be healthier. Sleep, stem cell activator and clonality Mostly when I bring […] The post Weekly reads: stem cell activator, sleep & stem cells, clonal hematopoiesis ap…

When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade. It’s really that promising even though there are […] The post ViaCyte purchase puts Vertex in driver’s seat on stem cells for diabetes ap…

People are the real driving force in the stem cell and regenerative medicine field including my colleague Jan Nolta here at UC Davis. She is the Director of our Stem Cell Program. There’s also news about Stanford’s stem cell Director Irv Weissman. Jan Nolta receives award Jan’s lab is prolific and in many ways is […] The post Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidan…

The use of human embryos in stem cell research can create moral unease, as embryos are usually destroyed when researchers extract stem cells from them. If one considers the embryo as a potential life, this can be perceived as a human life opportunity being extinguished. At the same time, stem cell research aims to support […] The post Using surplus embryos to treat Parkinson’s disease: perception…

UVA Author: Nafiisha Genet Citation: Genet N, Bhatt N, Bourdieu A, Hirschi KK. Multifaceted Roles of Connexin 43 in Stem Cell Niches. Curr Stem Cell Rep. 2018;4(1):1-12. doi:10.1007/s40778-018-0110-3 DOI: https://doi.org/10.1007/s40778-018-0110-3 Pub-Med Number: 29600160 Purpose of review: Considerable progress has been made in the field of stem cell research; nonetheless, the use of stem cells f…

We’ll begin this week’s recommended reads with some news on two wonderful stem cell scientists. While there are thousands of stem cell scientists, some stand out for their especially creative work. News on stem cell scientists   Nobel laureate Yamanaka to retire as director of iPS cell center, Asahi Shimbun. Dr. Yamanaka will spend more time […] The post Recommended reads: stem cell scientists, e…

In a building at the edge of the Massachusetts General Hospital (MGH) complex, Ömer Yilmaz, MD, and a group of pathology residents gather around a microscope. A resident reads from a chart: a growth was found in the intestine of a patient who had complained of abdominal pain. Yilmaz, an MIT cancer researcher and a […] The post Stem Cell Research Zeroes in on Cancer appeared first on MIT Departmen…

Over 1,500 researchers recently joined the 8th annual Gibco™ 5 Days of Stem Cells Virtual Event around the world on October 12-16, 2020. The 5-day event connected attendees to the latest advances in stem cell research through scientific presentations, poster sessions, virtual training opportunities and much more. Here’s what they had to say about the The post A Look Back: Gibco 5 Days of Stem Cel…

David Brafman David Brafman will be establishing the ASU Stem Cell Training and Research (STaR) program thanks to a grant from Women & Philanthropy, an ASU Foundation group which awards four ASU grants per year, including one in the field of biomedicine. The group awarded him one of the annual grants it awards to fund work by ASU faculty that is deemed to have potential for solving some of societ…

Reading Time: 4 minutes The recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem The post Stem cell trials in the news appeared first on MND Research Blog .

Parkinson's disease occurs when nerve cells in the brain that are responsible for producing dopamine, die or become impaired. Dopamine allows the body's muscles to move smoothly, and without it, a person slowly loses control of their movements. While the current treatment options for Parkinson's help to replenish a patient's dopamine levels, they are often only a short-term fix and can have sever…